🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8759327

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8754050

Macrocyclic compounds useful as inhibitors of histone deacetylases

The Regents of the University of Colorado · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8754080

Pyrimidine substituted purine compounds as kinase (S) inhibitors

VERASTEM, INC. · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8754034

Structure-based design of peptide inhibitors of amyloid fibrillation

The Regents of the University of California · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748601

Selective serine/threonine kinase inhibitors

The Regents of the University of California · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748607

Imidazopyrizine syk inhibitors

GILEAD CONNECTICUT, INC. · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8747843

Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as

The Board of Regents of the University of Texas System · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741898

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8742121

Process for the preparation of small molecule inhibitors of MDM2 and intermediates used th

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741937

Gamma glutamyl transpeptidase inhibitors and methods of use

The Board of Regents of the University of Oklahoma · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741912

Deazapurines useful as inhibitors of Janus kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735418

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735593

Aminopyridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8729039

Use of inhibitory oligonucleotides to treat autoimmune disease

The Regents of the University of California · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8729053

Nuclear factor kappa B pathway inhibitor composition and use of same

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8729119

Serotonin reuptake inhibitors

Theravance, Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8722895

Prolyl hydroxylase inhibitors and method of use

Akebia Therapeutics, Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8722889

Azaindoles useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8722708

Substituted isoindolines as aspartyl protease inhibitors

Pharmacopeia Drug Discovery, Inc. · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8715649

Compositions and methods of use for alpha-1 antitrypsin having no significant serine prote

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8716473

Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase

SENTINEL ONCOLOGY LIMITED · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8716315

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8716301

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710081

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted